Skip to content

DBV Technologies DBVT Net Change in Cash

Net Change in Cash at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$9.21M+197%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$13.25M-109%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$6.86M+161%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$134.46M+2,610%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-$212.91M-603%
Alumis Inc. logo
Alumis Inc.ALMS
-$25.78M+37.0%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+259%
Enterprise value$700.21M+179%
P/S159.6×+87.1×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's net change in cash?
DBV Technologies (DBVT) reported net change in cash of $35M in Q1 2026.
How has DBV Technologies's net change in cash changed year-over-year?
DBV Technologies's net change in cash increased by 279.5% year-over-year, from -$19.5M to $35M.
What is the long-term trend for DBV Technologies's net change in cash?
Over 2 years (2021 to 2024), DBV Technologies's net change in cash has grown at a -4.4% compound annual growth rate (CAGR), from -$119.05M to -$108.91M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.